Titan Pharmaceuticals
TTNP
#10392
Rank
HK$47.66 M
Marketcap
HK$35.83
Share price
-3.76%
Change (1 day)
27.81%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.12. In 2023 the company made an earnings per share (EPS) of -HK$57.60 an increase over its 2022 EPS that were of -HK$118.07.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.60-51.22%
2022-HK$118.07-15.61%
2021-HK$139.91-81.37%
2020-HK$750.84-77.52%
2019-HK$3,341-56.32%
2018-HK$7,648-59.51%
2017-HK$18,892-371.81%
2016HK$6,950-144.35%
2015-HK$15,670300%
2014-HK$3,917-121.54%
2013HK$18,188-151.38%
2012-HK$35,397-11.54%
2011-HK$40,014188.89%
2010-HK$13,851-10%
2009-HK$15,390
2007-HK$63,099-2.38%
2006-HK$64,638-39.13%
2005-HK$106,192-16.87%
2004-HK$127,738-22.43%
2003-HK$164,6744.9%
2002-HK$156,97961.9%
2001-HK$96,958-13.7%
2000-HK$112,34865.01%
1999-HK$68,086-35.87%
1998-HK$106,173-1824.71%
1997HK$6,156-102.4%
1996-HK$257,014

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-HK$11.04-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.94-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.27-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.14-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.21-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA